Leading Global Pharma CDMO
Contract Developer & Manufacturer
Aenova - Your Partner for Third-Party Manufacturing & Development Services
Aenova is a global leader in contract development and third-party manufacturing (CDMO) services for the pharmaceutical and healthcare industries.
With a robust network of advanced manufacturing sites across Europe and the U.S., we offer end-to-end solutions in third-party manufacturing, contract production, pharmaceutical packaging, and drug product development for clients worldwide.
Using state-of-the-art facilities and cutting-edge technologies, we provide tailored solutions for pharmaceutical, consumer health, and veterinary markets worldwide.
About Aenova Group
Since its formation through key strategic mergers and acquisitions, Aenova has evolved into one of the world’s most trusted CDMO partners.
Founded in 2008, Aenova Group was created through the merger of pharmaceutical companies Dragenopharm and Swiss Caps, forming the nucleus of the group. In 2012, the Temmler Group was acquired, and at the beginning of 2014 Haupt Pharma was acquired.
Since then, Aenova has grown to become one of the world's premier pharmaceutical CDMO companies. Our 4,000+ skilled employees, innovative technologies, and unwavering commitment to quality make us the partner of choice for pharmaceutical companies seeking reliable third party manufacturing and contract services.
The majority shareholder of Aenova is Kühne Holding AG.
Our Milestones to a Globally Leading CDMO:
2008
2008
Foundation of Aenova Group
2008
2024
2024
Aenova achieves record results once again
2024
2023
2023
Aenova further expands in capacities and innovative technologies
2023
2021
2020 - 2022
Largest investment program in differentiated technologies/ innovation in corporate history
2021
2020
2020
Expansion III Tittmoning solids (SOL)
Gronau sterile ampoules expansion
2020
Main corporate events
Main manufacturing/services events
The Aenova Group Network
Aenova's network consists of 14 manufacturing and development sites, each fulfilling a specific role within the group by specializing in differentiated technology and service offerings.
Aenova’s strong commitment to impeccable quality is demonstrated by our adherence to the highest regulatory standards and certifications.
We invest continuously in differentiated technologies and innovation, ensuring our manufacturing and packaging processes meet the evolving needs of the pharmaceutical industry.
Proven Experience: Decades of success as a trusted CDMO and third-party pharmaceutical manufacturer for the biggest pharma corporations in the world as well as a multitude of mid-sized and start-up companies.
Global Reach: Operations across Europe, the U.S., and global markets, serving pharmaceutical, biopharmaceutical, and nutraceutical clients.
Comprehensive CDMO Services: From early-stage drug formulation to clinical trial and commercial supply, from production to packaging and regulatory support — all under one roof.
Technology & Innovation: Continuous investment in next-generation technologies to improve speed, scalability, and product quality.
Our Manufacturing Capabilities for Pharmaceutical and Nutraceutical Products
We deliver a comprehensive suite of GMP-certified pharmaceutical manufacturing services designed to support your product’s journey from concept to market. Our expertise covers a wide spectrum of dosage forms, including the development and production of solid oral forms, semi-solid formulations like creams and gels, and advanced sterile manufacturing technologies for injectables. Our offering includes third-party manufacturing of nutraceuticals or food supplements in various product forms, too.
Beyond manufacturing, we also offer high-volume commercial and customized pharmaceutical packaging - including options for food supplements - with the capabilities to ensure your products meet global regulatory requirements and reach the market with speed and reliability.
Our Pharmaceutical Development & Technology Capabilities
Our integrated development and technology services support clients throughout the entire product lifecycle. We specialize in drug product development across all major dosage forms, including complex and high-potency compounds.
LinkedIn
Instagram
Facebook